Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMIQUIMOD
- Skin Inflammation and PK of Azithromycin
- Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
- Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts
- Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
- Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
- Evaluation of the Immunopharmacology of EDP1815 and EDP2939
- Coadministration of GA2 Sporozoites With Adjuvants
- A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts
- Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
- Efficacy of Tazarotene in Treatment of Verruca Plana
- Chinese Medicine for Patients With Psoriasis
- Basal Cell Carcinoma Chemoprevention Trial
- A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts
- Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
- A Trial to Learn How BAY1834845 and BAY1830839 Affect Inflammation When Taken by Mouth Twice a Day for 7 Days in a Row in Healthy Male Participants
- Topical Aldara (Imiquimod) for Oral Cancer
- Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ
- Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
- Intralesional Triamcinolone Acetonide and Its Combination With 5-fluorouracil in Keloids and Hypertrophic Scars
- Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
- Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
- Topical Vitamin C for Treatment of Basal Cell Cancer
- Portable Measurement of Protoporphyrin IX in the Skin During Photodynamic Therapy
- Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
- Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% as a New Surrogate Model of Itch
- Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
- Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study
- A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts
- Imiquimod for Preventing Keloid Recurrence
- Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma
- A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
- H5N1 With or Without Topical Aldara in Healthy Adults
- Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC
- Daylight Photodynamic Therapy for Actinic Keratosis
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial
- Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
- Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions
- Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
- Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
- CTCL Directed Therapy
- Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers
- Imiquimod and Influenza Vaccine for Immunocompromised Patients
- Imiquimod Treatment of High-grade CIN
- Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
- iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL
- Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face
- Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
- Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
- Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Efficacy and Tolerability of Topical LFX453 for External Genital Warts
- Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
- Radiotherapy or Imiquimod in Complex Lentigo Maligna
- Topical 5% Imiquimod Cream for Vulvar Paget's Disease
- The Real Life Topical Field Treatment of Actinic Keratosis Study
- Imiquimod Treatment of CIN Lesions
- Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
- HER2-Peptide Vaccination of Patients With Solid Tumors
- Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
- Pilot Study of DRibble Vaccine for Prostate Cancer Patients
- Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
- Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
- Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
- A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses
- Intradermal Influenza Vaccine in the Young
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions
- A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453
- Topical Green Tea Ointment in Treatment of Superficial Skin Cancer
- Photoaging Treatment With Imiquimod
- Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
- Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
- Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
- Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
- Dendritic Cell Vaccine for Children and Adults With Sarcoma
- Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
- Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.
- Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
- Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
- Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas
- Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
- Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head
- Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
- A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects
- Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients
- Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients
- Intradermal Trivalent Influenza Vaccine With Imiquimod
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
- Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
- Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
- Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
- Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
- Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia
- Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
- Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
- Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
- Effect of Topical Imiquimod on Lentigo Maligna
- Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
- Comparison of Five Treatments in Patients With Plantar Warts
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
- The Effects of Aldara as an Adjunct to Laser Treatment
- Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
- Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment
- ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
- Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
- Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
- Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy
- Bioequivalence Study of Two Imiquimod Cream 5%
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
- Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
- Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
- Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
- IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses
- Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
- Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients
- Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
- Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
- Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
- Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
- Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
- Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
- A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
- Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
- Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks
- Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
- Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
- A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base
- Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
- Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
- Topical Imiquimod for Bowen's Disease of the Head and Neck
- Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
- Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
- Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
- Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
- Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
- Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
- Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma
- Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
- Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
- Aldara for the Treatment of Large and/or Multiple sBCC
- A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
- A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
- A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
- Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
- Imiquimod in Children With Plaque Morphea
- NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
- A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
- Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
- Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
- Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
- 1-Year Follow up to the 1473-IMIQ Study
- Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
- Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
- Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
- Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Clinical trials list
click for details